fingolimod hydrochloride has been researched along with dihydroceramide in 1 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (dihydroceramide) | Trials (dihydroceramide) | Recent Studies (post-2010) (dihydroceramide) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 159 | 2 | 88 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berdyshev, EV; Bittman, R; Dudek, SM; Garcia, JG; Gorshkova, I; Lu, X; Mirzapoiazova, T; Natarajan, V; Skobeleva, A | 1 |
1 other study(ies) available for fingolimod hydrochloride and dihydroceramide
| Article | Year |
|---|---|
FTY720 inhibits ceramide synthases and up-regulates dihydrosphingosine 1-phosphate formation in human lung endothelial cells.
Topics: Cells, Cultured; Ceramides; Chromatography, Liquid; Endothelium, Vascular; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Lung; Lysophospholipids; Oxidoreductases; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Propylene Glycols; Pulmonary Artery; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Serine C-Palmitoyltransferase; Sphingosine; Tandem Mass Spectrometry; Up-Regulation | 2009 |